Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae Hyung Kim, So Yeon Kim, An Tang, et al.
Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 3, pp. 245-263
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Hepatocellular carcinoma
Alexandra M. Adams, Ahmed O. Kaseb, Hop S. Tran Cao
Elsevier eBooks (2024), pp. 27-39
Closed Access | Times Cited: 17
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee, et al.
Gut (2019) Vol. 69, Iss. 7, pp. 1301-1308
Open Access | Times Cited: 127
Novel biomarkers for the management of chronic hepatitis B
Takako Inoue, Yasuhito Tanaka
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 3, pp. 261-279
Open Access | Times Cited: 113
Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
Hyo Jung Cho, Jung Woo Eun, Geum Ok Baek, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 281-281
Open Access | Times Cited: 103
Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications
Hyungjin Rhee, Eun‐Suk Cho, Ji Hae Nahm, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 109-121
Closed Access | Times Cited: 97
Advances in Novel Diagnostic Techniques for Alveolar Echinococcosis
Huan‐Huan Liu, Yong Xie, Xiaoyu An, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 585-585
Open Access | Times Cited: 1
LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI
Sang Min Lee, Jeong Min Lee, Su Joa Ahn, et al.
Radiology (2019) Vol. 292, Iss. 3, pp. 655-663
Closed Access | Times Cited: 61
CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
Sunyoung Lee, Yeun‐Yoon Kim, Jaeseung Shin, et al.
Journal of the American College of Radiology (2020) Vol. 17, Iss. 10, pp. 1199-1206
Closed Access | Times Cited: 61
Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid–enhanced MRI: A Multicenter Study
Ijin Joo, So Yeon Kim, Tae Wook Kang, et al.
Radiology (2020) Vol. 296, Iss. 2, pp. 335-345
Open Access | Times Cited: 56
Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
Hyo Jung Cho, Geum Ok Baek, Chul Won Seo, et al.
Cancer Medicine (2020) Vol. 9, Iss. 15, pp. 5459-5472
Open Access | Times Cited: 54
Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
Sunyoung Lee, Seung‐seob Kim, Dong Ryul Chang, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 3, pp. 340-351
Open Access | Times Cited: 50
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
Zobair M. Younossi, Sean Felix, Thomas L. Jeffers, et al.
JAMA Network Open (2021) Vol. 4, Iss. 9, pp. e2123923-e2123923
Open Access | Times Cited: 47
Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review
Liang Meng Loy, Hsien Min Low, Jin‐Young Choi, et al.
American Journal of Roentgenology (2022) Vol. 219, Iss. 2, pp. 212-223
Closed Access | Times Cited: 32
Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis
Shoubin Zhan, Ping Yang, Shengkai Zhou, et al.
Frontiers of Medicine (2022) Vol. 16, Iss. 2, pp. 216-226
Closed Access | Times Cited: 32
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 197-205
Open Access | Times Cited: 22
Image Quality and Diagnostic Performance of Low-Dose Liver CT with Deep Learning Reconstruction versus Standard-Dose CT
Dong Ho Lee, Jeong Min Lee, Chang Hee Lee, et al.
Radiology Artificial Intelligence (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 6
Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea
Myung Ji Goh, Joo Hyun Oh, Yewan Park, et al.
Liver Cancer (2021) Vol. 10, Iss. 1, pp. 52-62
Open Access | Times Cited: 40
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
Sumeet K. Asrani, Marwan Ghabril, Alexander Kuo, et al.
Hepatology (2021) Vol. 75, Iss. 5, pp. 1289-1299
Open Access | Times Cited: 36
A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC
Jaejun Lee, Pil Soo Sung, Hyun Yang, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 4121-4121
Open Access | Times Cited: 35
Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 29, Iss. 4, pp. 832-837
Closed Access | Times Cited: 33
Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis
Tae‐Hyung Kim, Haeryoung Kim, Ijin Joo, et al.
Korean Journal of Radiology (2020) Vol. 21, Iss. 10, pp. 1115-1115
Open Access | Times Cited: 33
Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Hyo Jung Cho, Jae Youn Cheong
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8011-8011
Open Access | Times Cited: 31
Clinical Value of Machine Learning-Based Ultrasomics in Preoperative Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Multicenter Study
Shanshan Ren, Qian Li, Shunhua Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
Guilherme Moura Cunha, Victoria Chernyak, Kathryn J. Fowler, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 513-527
Open Access | Times Cited: 29
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10027-10027
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top